Multiple Sclerosis Discovery Forum

Inspiring Connections

Utility Navigation

User Top Menu

Drug Development

The MSDF Drug-Development Pipeline

The founder and curator of MSDF’s drug database reveals how it keeps you up to date with experimental and approved therapies in MS and related demyelinating diseases
Dozens of new MS drug-related developments are published in scientific papers or described in...
Clinical Research, Drug Development

MS Research Roundup: 27 February 2016

Research Roundup logo
FDA Fast-Tracks PPMS Drug Review; Molecular Target Runs Out of Air; Happy Accidents in the Lab; New Twist on Patient-Powered Research
Items of interest to multiple sclerosis researchers from around the Web...
Clinical Research, Drug Development, Laboratory Research, Meetings, People

Taking Studies of Sex Differences to the Next Level

Rhonda Voskuhl
It is now over a year since the announcement of a new National Institutes of Health policy to encourage...
Multiple sclerosis affects about three times more women than men, but pregnancy can protect against relapses, and MS in men tends to worsen faster. These naturally occurring sex differences could lead to new treatments—if they don’t stall on the way to the clinic.
Clinical Research, Drug Development, Laboratory Research

PodBlog: B-Cell Double Header

Podcast logo
In episodes 56 and 57 of the MS Discovery podcast, Gavin Giovannoni, MBBCH, PhD, and Timothy Vollmer, MD, discuss the first large-scale study of a drug showing some benefits in a progressive form of multiple sclerosis. The story goes back decades, as Stephen Hauser, MD, recently explained.
A former beauty queen made a big impression on Stephen Hauser, MD, when he was...
Clinical Research, Drug Development, Laboratory Research, Meetings, People


Subscribe to RSS - Drug Development